Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase Cγ pathway: Blocking angiogenin inhibits latent gene expression and induces the lytic cycle

Journal of Virology

Volumn 85, Issue 6, 2011, Pages 2666-2685

  Sadagopan, Sathish ^a   Veettil, Mohanan Valiya ^a   Paudel, Nitika ^a   Bottero, Virginie ^a   Chandran, Bala ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ANGIOGENIN; NEOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE C GAMMA;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPORT; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE SILENCING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOBLASTOID CELL LINE; LYMPHOMA CELL; LYSIS; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SUPERNATANT; VIRUS LATENCY;

CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; LYMPHOMA, PRIMARY EFFUSION; PHOSPHOLIPASE C GAMMA; RIBONUCLEASE, PANCREATIC; VIRUS LATENCY;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 79952411473     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01532-10     Document Type: Article

References (52)

1. An, F. Q., et al. 2006. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J. Virol. 80:4833-4846.
2. Areste, C., and D. J. Blackbourn. 2009. Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus. Trends Microbiol. 17:119-129.
3. Boss, I. W., K. B. Plaisance, and R. Renne. 2009. Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol. 17:544-553.
4. Cesarman, E., Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191.
5. Chandriani, S., and D. Ganem. 2010. Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 84:5565-5573.
6. Chang, Y., et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
7. Cohen, A., C. Brodie, and R. Sarid. 2006. An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol. 87:795-802.
8. Dull, T., et al. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471. (Pubitemid 28471781)
9. Favata, M. F., et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623-18632.
10. Ford, P. W., et al. 2006. Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency. J. Gen. Virol. 87:1139-1144.
11. Friborg, J., Jr., W. Kong, M. O. Hottiger, and G. J. Nabel. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889-894.
12. Ganem, D. 2007. Kaposi's sarcoma-associated herpesvirus, vol. 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
13. Ganem, D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol. 1:273-296.
14. Gao, T., F. Furnari, and A. C. Newton. 2005. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18:13-24.
15. Guasparri, I., S. A. Keller, and E. Cesarman. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199:993-1003.
16. Hatzi, E., Y. Bassaglia, and J. Badet. 2000. Internalization and processing of human angiogenin by cultured aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 267:719-725.
17. Hirukawa, S., K. A. Olson, T. Tsuji, and G. F. Hu. 2005. Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice. Clin. Cancer Res. 11:8745-8752.
18. Hu, G. F. 1998. Neomycin inhibits angiogenin-induced angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 95:9791-9795.
19. Hu, G., C. Xu, and J. F. Riordan. 2000. Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA. J. Cell. Biochem. 76:452-462.
20. Ibaragi, S., et al. 2009. Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription. Clin. Cancer Res. 15:1981-1988.
21. Kim, H. M., D. K. Kang, H. Y. Kim, S. S. Kang, and S. I. Chang. 2007. Angiogenin-induced protein kinase B/Akt activation is necessary for angiogenesis but is independent of nuclear translocation of angiogenin in HUVE cells. Biochem. Biophys. Res. Commun. 352:509-513.
22. Kishimoto, K., S. Liu, T. Tsuji, K. A. Olson, and G. F. Hu. 2005. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24:445-456.
23. Krishnan, H. H., et al. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78:3601-3620. (Pubitemid 38568301)
24. Lan, K., D. A. Kuppers, S. C. Verma, and E. S. Robertson. 2004. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J. Virol. 78:6585-6594.
25. Lee, J. S., et al. 2009. FLIP-mediated autophagy regulation in cell death control. Nat. Cell Biol. 11:1355-1362.
26. Liu, J., H. J. Martin, G. Liao, and S. D. Hayward. 2007. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc. J. Virol. 81:10451-10459.
27. Liu, S., D. Yu, Z. P. Xu, J. F. Riordan, and G. F. Hu. 2001. Angiogenin activates Erk1/2 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 287:305-310.
28. Lodhi, S., N. D. Weiner, and J. Schacht. 1976. Interactions of neomycin and calcium in synaptosomal membranes and polyphosphoinositide monolayers. Biochim. Biophys. Acta 426:781-785.
29. Margolis, B., et al. 1989. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 57:1101-1107. (Pubitemid 19169806)
30. Matta, H., et al. 2007. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation. J. Biol. Chem. 282:24858-24865.
31. Matta, H., et al. 2007. Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8-encoded viral FLICE inhibitory protein K13. Oncogene 26:1656-1660. (Pubitemid 46398733)
32. Miyoshi, H., U. Blomer, M. Takahashi, F. H. Gage, and I. M. Verma. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150-8157.
33. Moore, F., and J. F. Riordan. 1990. Angiogenin activates phospholipase C and elicits a rapid incorporation of fatty acid into cholesterol esters in vascular smooth muscle cells. Biochemistry 29:228-233.
34. Moroianu, J., and J. F. Riordan. 1994. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc. Natl. Acad. Sci. U. S. A. 91:1677-1681.
35. Naranatt, P. P., et al. 2004. Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res. 64:72-84. (Pubitemid 38114084)
36. Nun, T. K., et al. 2007. Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus. Mol. Cancer Ther. 6:2360-2370.
37. Olson, K. A., T. C. French, B. L. Vallee, and J. W. Fett. 1994. A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res. 54:4576-4579.
38. Peng, L., et al. 2010. Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency. J. Gen. Virol. 91:463-469.
39. Sadagopan, S., et al. 2009. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. J. Virol. 83:3342-3364.
40. Sadagopan, S., et al. 2007. Kaposi's sarcoma-associated herpesvirus induces sustained NF-κB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J. Virol. 81:3949-3968. (Pubitemid 46586891)
41. Sarid, R., J. S. Wiezorek, P. S. Moore, and Y. Chang. 1999. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J. Virol. 73: 1438-1446. (Pubitemid 29036799)
42. Sharma-Walia, N., et al. 2005. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J. Virol. 79:10308-10329. (Pubitemid 41098572)
43. Sharma-Walia, N., et al. 2010. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog. 6:e1000777.
44. Sharma-Walia, N., et al. 2006. Cyclooxygenase 2 induced by Kaposi's sarcoma- associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J. Virol. 80:6534-6552. (Pubitemid 43927455)
45. Soulier, J., et al. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
46. Vart, R. J., et al. 2007. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res. 67:4042-4051. (Pubitemid 46815049)
47. Verselis, S. J., K. A. Olson, and J. W. Fett. 1999. Regulation of angiogenin expression in human HepG2 hepatoma cells by mediators of the acute-phase response. Biochem. Biophys. Res. Commun. 259:178-184.
48. Wang, L., and B. Damania. 2008. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res. 68:4640-4648.
49. Wiedlocha, A. 1999. Following angiogenin during angiogenesis: a journey from the cell surface to the nucleolus. Arch. Immunol. Ther. Exp. (Warsz.) 47:299-305.
50. Xie, J., A. O. Ajibade, F. Ye, K. Kuhne, and S. J. Gao. 2008. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 371:139-154.
51. Xu, Z. P., T. Tsuji, J. F. Riordan, and G. F. Hu. 2003. Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry 42:121-128.
52. Yuan, Y., et al. 2009. Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis. Lung Cancer 66:28-36.